2. Abstract
Introduction Patients with acute renal failure requiring hemodialysis should use temporary hemodialysis catheters (THC) due to the urgency and potential reversibility of the condition. So far, three studies in North America indicate a higher risk of catheter-related issues in COVID-19 patients needing hemodialysis. This study examines the functionality and complications of temporary hemodialysis access in COVID-19 patients at a Brazilian hospital.
Methodology A prospective analysis was conducted at a COVID-19 referral center between May and July 2020. During this time, the Vascular Surgery team implanted temporary hemodialysis catheters in 107 patients. The patients were followed, and demographic and clinical characteristics that could be correlated with catheter malfunction were analyzed.
Results Of the 107 patients studied, 22 (20,6%) experienced complications related to the catheter. Eighteen (16,8%) had malfunctions, and 4 (3,7%) had infections. Five patients evolved with unfavorable clinical conditions and did not undergo catheter replacement. Thirteen patients with malfunctions had catheter tip thrombosis as the cause of the malfunction. Among the variables analyzed, only the need for orotracheal intubation (p 0,009), deep vein thrombosis (p 0,01), and a history of a previous catheter (p 0,002) were found to be correlated with a higher risk of malfunctioning.
Conclusion The rate of temporary high-flow catheter malfunction in patients with COVID-19 is similar to that in patients without this disease. Previous catheter use, the necessity for OTI, and venous thrombosis were the main predictors of catheter malfunction.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Hospital Israelita Albert Einstein - SP gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
No disclosures. The authors declare that they have no conflicts of interest.
Data Availability
All data produced in the present work are contained in the manuscript.
